Pacritinib Combined With Decitabine or Cytarabine in Older Patients With AML

Stopped The study was put on clinical hold by the sponsor since Feb 9th 2016, and was later decided not to re-open due to financial constraints.

Conditions

• Acute Myeloid Leukemia (AML)

Interventions

• DRUG: Pacritinib
• DRUG: Decitabine
• DRUG: Cytarabine

Sponsor

Weill Medical College of Cornell University